Search 25,000+ prices/
Brand prices in South Africa

Remsima Price in South Africa (2026)

Compiled by the TrustClinix data team · Medical review pending2 official sourcesPrices last checked 25 October 2026How we get our data
Lowest Single Exit Price (SEP)
R2,001

Remsima (infliximab): 100 MG/Vial injection, 10. Official SEP list, Oct 2026.

≈ $121
R2,001
per pack
1
strength
1
listed pack
Lowest
already the cheapest
Cheapest

Remsima is already the lowest-priced infliximab 100 mg injection on the official list in South Africa.

3 brands

of infliximab are listed in South Africa, including Remiflix and Revellex.

3 countries

list Remsima: South Africa, Saudi Arabia and United Arab Emirates.

Every listed pack

Remsima strengths, packs and prices in South Africa

Remsima official prices in South Africa
ProductStrength and formPackPricePer unit
Remsima 100 mg/Vial100 MG/Vial injection10R2,001—

Remsima is sold in South Africa as 100 mg injection. The official list names Adcock Ingram Limited as the manufacturer. It is a Schedule 4 medicine. The South African price database marks it as a generic.

Same ingredient, same strength

Remsima vs other infliximab 100 mg injection in South Africa

Remsima (this page)R2,001
RemiflixR2,849
RevellexR3,345
infliximab 100 mg injection: price per pack (ZAR)
Alternatives
ProductPackPricePer unit
Remiflix10R2,849—
Revellex1R3,345—

Products with the same active ingredient, strength and form are usually interchangeable, but check with your doctor or pharmacist before switching, especially for modified-release forms.

Same brand, other countries

Remsima price in other countries

By country
CountryPacksCheapest pack (local)In USDPrice type
South Africa (this page)1R2,001$121Single Exit Price (SEP)
Saudi Arabia1SAR 1,357$362SFDA public price
United Arab Emirates1AED 1,802$491Abu Dhabi DoH public price

Pack sizes differ between countries, and each country publishes a different kind of price.

What this price means

How SEPs work in South Africa

Prices on this page are the Single Exit Price: the one legal price at which the manufacturer may sell the pack in South Africa, including VAT and a logistics fee. Pharmacies and dispensing doctors add a regulated dispensing fee plus VAT on top. For cheap medicines this fee is a large share of what you pay, and can be more than the medicine itself, so the counter price can be much higher than the SEP. Medical schemes may pay all or part of it.

See every infliximab product and price in South Africa, or read the guide to medicine prices in South Africa.

Other brands of infliximab

Infliximab brands in South Africa

Keep exploring

What people check next

Quick answers

Frequently asked questions

How much does Remsima cost in South Africa?
Remsima costs R2,001. This is the Single Exit Price.
What is the generic name of Remsima?
Remsima contains infliximab. Medicines with the same active ingredient, strength and form work the same way, though inactive ingredients can differ.
Is there a cheaper alternative to Remsima in South Africa?
Remsima is already among the cheapest infliximab 100 mg injection products on the official list in South Africa.
Who makes Remsima?
The official list names Adcock Ingram Limited as the manufacturer of Remsima products sold in South Africa.
What schedule is Remsima in South Africa?
Remsima is a Schedule 4 medicine in South Africa. Schedule 0–1 medicines can be sold without a prescription; Schedule 3 and above need one.
Evidence

Sources

  1. National Department of Health, South Africa. Database of Medicine Prices (Single Exit Price), effective 1 October 2026. www.health.gov.za/nhi-pee/. Retrieved 25 October 2026.
  2. European Central Bank. Euro foreign exchange reference rates (2026-10-23). www.ecb.europa.eu/stats/eurofxref/eurofxref-daily.xml. Retrieved 25 October 2026.

Important: These are published reference prices and estimates, not a quote, and not medical advice. Actual costs depend on the hospital, your health, the exact treatment and your insurance. Always confirm the price with the provider before treatment. Read our disclaimer · Report an error